Transcriptional networks of progressive diabetic peripheral neuropathy in the db/db mouse model of type 2 diabetes: An inflammatory story

Lucy M. Hinder, Benjamin J. Murdock, Meeyoung Park, Diane E. Bender, Phillipe D. O'Brien, Amy E. Rumora, Junguk Hur, Eva L. Feldman

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Diabetic peripheral neuropathy is the most common complication of diabetes and a source of considerable morbidity. Numerous molecular pathways are linked to neuropathic progression, but it is unclear whether these pathways are altered throughout the course of disease. Moreover, the methods by which these molecular pathways are analyzed can produce significantly different results; as such it is often unclear whether previously published pathways are viable targets for novel therapeutic approaches. In the current study we examine changes in gene expression patterns in the sciatic nerve (SCN) and dorsal root ganglia (DRG) of db/db diabetic mice at 8, 16, and 24 weeks of age using microarray analysis. Following the collection and verification of gene expression data, we utilized both self-organizing map (SOM) analysis and differentially expressed gene (DEG) analysis to detect pathways that were altered at all time points. Though there was some variability between SOM and DEG analyses, we consistently detected altered immune pathways in both the SCN and DRG over the course of disease. To support these results, we further used multiplex analysis to assess protein changes in the SCN of diabetic mice; we found that multiple immune molecules were upregulated at both early and later stages of disease. In particular, we found that matrix metalloproteinase-12 was highly upregulated in microarray and multiplex data sets suggesting it may play a role in disease progression.

Original languageEnglish (US)
Pages (from-to)33-43
Number of pages11
JournalExperimental Neurology
Volume305
DOIs
StatePublished - Jul 2018

Fingerprint

Diabetic Neuropathies
Gene Regulatory Networks
Peripheral Nervous System Diseases
Sciatic Nerve
Type 2 Diabetes Mellitus
Spinal Ganglia
Matrix Metalloproteinase 12
Gene Expression
Diabetes Complications
Microarray Analysis
Genes
Disease Progression
Morbidity
Proteins
Therapeutics

Keywords

  • Diabetes
  • Diabetic peripheral neuropathy
  • Gene expression analysis
  • Immune system
  • Inflammation
  • Microarray
  • Mouse models
  • Self-organizing map
  • db/db

ASJC Scopus subject areas

  • Neurology
  • Developmental Neuroscience

Cite this

Transcriptional networks of progressive diabetic peripheral neuropathy in the db/db mouse model of type 2 diabetes : An inflammatory story. / Hinder, Lucy M.; Murdock, Benjamin J.; Park, Meeyoung; Bender, Diane E.; O'Brien, Phillipe D.; Rumora, Amy E.; Hur, Junguk; Feldman, Eva L.

In: Experimental Neurology, Vol. 305, 07.2018, p. 33-43.

Research output: Contribution to journalArticle

Hinder, Lucy M. ; Murdock, Benjamin J. ; Park, Meeyoung ; Bender, Diane E. ; O'Brien, Phillipe D. ; Rumora, Amy E. ; Hur, Junguk ; Feldman, Eva L. / Transcriptional networks of progressive diabetic peripheral neuropathy in the db/db mouse model of type 2 diabetes : An inflammatory story. In: Experimental Neurology. 2018 ; Vol. 305. pp. 33-43.
@article{bff05e0eb4b944379212825ed0b5ec04,
title = "Transcriptional networks of progressive diabetic peripheral neuropathy in the db/db mouse model of type 2 diabetes: An inflammatory story",
abstract = "Diabetic peripheral neuropathy is the most common complication of diabetes and a source of considerable morbidity. Numerous molecular pathways are linked to neuropathic progression, but it is unclear whether these pathways are altered throughout the course of disease. Moreover, the methods by which these molecular pathways are analyzed can produce significantly different results; as such it is often unclear whether previously published pathways are viable targets for novel therapeutic approaches. In the current study we examine changes in gene expression patterns in the sciatic nerve (SCN) and dorsal root ganglia (DRG) of db/db diabetic mice at 8, 16, and 24 weeks of age using microarray analysis. Following the collection and verification of gene expression data, we utilized both self-organizing map (SOM) analysis and differentially expressed gene (DEG) analysis to detect pathways that were altered at all time points. Though there was some variability between SOM and DEG analyses, we consistently detected altered immune pathways in both the SCN and DRG over the course of disease. To support these results, we further used multiplex analysis to assess protein changes in the SCN of diabetic mice; we found that multiple immune molecules were upregulated at both early and later stages of disease. In particular, we found that matrix metalloproteinase-12 was highly upregulated in microarray and multiplex data sets suggesting it may play a role in disease progression.",
keywords = "Diabetes, Diabetic peripheral neuropathy, Gene expression analysis, Immune system, Inflammation, Microarray, Mouse models, Self-organizing map, db/db",
author = "Hinder, {Lucy M.} and Murdock, {Benjamin J.} and Meeyoung Park and Bender, {Diane E.} and O'Brien, {Phillipe D.} and Rumora, {Amy E.} and Junguk Hur and Feldman, {Eva L.}",
year = "2018",
month = "7",
doi = "10.1016/j.expneurol.2018.03.011",
language = "English (US)",
volume = "305",
pages = "33--43",
journal = "Experimental Neurology",
issn = "0014-4886",
publisher = "Academic Press Inc.",

}

TY - JOUR

T1 - Transcriptional networks of progressive diabetic peripheral neuropathy in the db/db mouse model of type 2 diabetes

T2 - An inflammatory story

AU - Hinder, Lucy M.

AU - Murdock, Benjamin J.

AU - Park, Meeyoung

AU - Bender, Diane E.

AU - O'Brien, Phillipe D.

AU - Rumora, Amy E.

AU - Hur, Junguk

AU - Feldman, Eva L.

PY - 2018/7

Y1 - 2018/7

N2 - Diabetic peripheral neuropathy is the most common complication of diabetes and a source of considerable morbidity. Numerous molecular pathways are linked to neuropathic progression, but it is unclear whether these pathways are altered throughout the course of disease. Moreover, the methods by which these molecular pathways are analyzed can produce significantly different results; as such it is often unclear whether previously published pathways are viable targets for novel therapeutic approaches. In the current study we examine changes in gene expression patterns in the sciatic nerve (SCN) and dorsal root ganglia (DRG) of db/db diabetic mice at 8, 16, and 24 weeks of age using microarray analysis. Following the collection and verification of gene expression data, we utilized both self-organizing map (SOM) analysis and differentially expressed gene (DEG) analysis to detect pathways that were altered at all time points. Though there was some variability between SOM and DEG analyses, we consistently detected altered immune pathways in both the SCN and DRG over the course of disease. To support these results, we further used multiplex analysis to assess protein changes in the SCN of diabetic mice; we found that multiple immune molecules were upregulated at both early and later stages of disease. In particular, we found that matrix metalloproteinase-12 was highly upregulated in microarray and multiplex data sets suggesting it may play a role in disease progression.

AB - Diabetic peripheral neuropathy is the most common complication of diabetes and a source of considerable morbidity. Numerous molecular pathways are linked to neuropathic progression, but it is unclear whether these pathways are altered throughout the course of disease. Moreover, the methods by which these molecular pathways are analyzed can produce significantly different results; as such it is often unclear whether previously published pathways are viable targets for novel therapeutic approaches. In the current study we examine changes in gene expression patterns in the sciatic nerve (SCN) and dorsal root ganglia (DRG) of db/db diabetic mice at 8, 16, and 24 weeks of age using microarray analysis. Following the collection and verification of gene expression data, we utilized both self-organizing map (SOM) analysis and differentially expressed gene (DEG) analysis to detect pathways that were altered at all time points. Though there was some variability between SOM and DEG analyses, we consistently detected altered immune pathways in both the SCN and DRG over the course of disease. To support these results, we further used multiplex analysis to assess protein changes in the SCN of diabetic mice; we found that multiple immune molecules were upregulated at both early and later stages of disease. In particular, we found that matrix metalloproteinase-12 was highly upregulated in microarray and multiplex data sets suggesting it may play a role in disease progression.

KW - Diabetes

KW - Diabetic peripheral neuropathy

KW - Gene expression analysis

KW - Immune system

KW - Inflammation

KW - Microarray

KW - Mouse models

KW - Self-organizing map

KW - db/db

UR - http://www.scopus.com/inward/record.url?scp=85044480551&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85044480551&partnerID=8YFLogxK

U2 - 10.1016/j.expneurol.2018.03.011

DO - 10.1016/j.expneurol.2018.03.011

M3 - Article

C2 - 29550371

AN - SCOPUS:85044480551

VL - 305

SP - 33

EP - 43

JO - Experimental Neurology

JF - Experimental Neurology

SN - 0014-4886

ER -